Search for mutations (synonymous mutations excluded) in the main genes involved in thyroid cancer and in cell cycle, revealed TP53 mutations as the major oncogenic driver for ATC, being present in 65% of cases (Supplementary Table S5). Here, TP53 is linked to thyroid gland carcinoma.